Login / Signup

An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction.

Yanshijing ZhouZihui YangHong Zeng
Published in: Pharmacogenomics and personalized medicine (2024)
The risk signature of 6 AG-lncs might offer a novel prognostic biomarker and promisingly enhance BC immunotherapy's effectiveness.
Keyphrases
  • randomized controlled trial
  • systematic review
  • quantum dots
  • long non coding rna
  • long noncoding rna
  • young adults
  • drug induced
  • visible light